Articles from Biotech Financial Reports (November 1, 2001)

Title	Author	Type	Words
AKZO NOBEL'S PHARMA ON COURSE FOR DOUBLE-DIGIT GROWTH.		Company Profile	1910
CANTEL REPORTS 20% INCREASE IN INCOME FOR 4TH QUARTER.		Brief Article	463
CHARLES RIVER LABS RAISES 3RD QTR EARNINGS GUIDANCE.		Brief Article	396
HERCULES IN INVESTMENT NEGOTIATIONS WITH EUROPEAN FIRM.			410
PEDIATRIX EXPECTS TO EXCEED 2001 3RD QTR EPS GUIDANCE.		Brief Article	157
REGENERON SELLS $200M OF CONVERTIBLE SENIOR SUBORDINATE NOTES.		Brief Article	334